AnalystsSerge BelangerSerge Belanger's Stock Forecasts
AnalystsSerge Belanger
Analyst Ranking
Top 1%
#36 out of 5100 analysts
Average Return
+19.23%
Win Rate
55%209 out of 382
Risk vs Reward
Poor
Good
Serge Belanger's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Trevi Therapeutics IncTRVI | +337.31% | $2.60 | $11.37 | 2024-12-03 - 2025-11-14 | Buy |
Arcutis Biotherapeutics IncARQT | +297.44% | $2.34 | $9.30 | 2023-11-05 - 2024-11-05 | Buy |
Arcutis Biotherapeutics IncARQT | +297.44% | $2.34 | $9.30 | 2023-11-05 - 2024-11-05 | Buy |
Trevi Therapeutics IncTRVI | +278.35% | $2.91 | $11.01 | 2024-11-07 - 2025-11-07 | Buy |
Esperion Therapeutics IncESPR | +232.95% | $0.87 | $2.90 | 2025-05-06 - 2025-11-14 | Buy |
Serge Belanger Analyst Color
Get additional color on Serge Belanger's coverage of popular stocks
Serge Belanger's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cormedix IncCRMD | 19 | Buy | $16.00 | +42.35% | Maintains | 3 days ago |
Oculis Holding AgOCS | 2 | Buy | $36.00 | +83.67% | Reiterates | 4 days ago |
Amphastar Pharmaceuticals IncAMPH | 3 | Buy | $34.00 | +30.47% | Maintains | 8 days ago |
Newamsterdam Pharma Co NvNAMS | 10 | Buy | $46.00 | +19.95% | Maintains | 10 days ago |
Biocryst Pharmaceuticals IncBCRX | 18 | Buy | $18.00 | +154.24% | Maintains | 11 days ago |
Liquidia CorpLQDA | 33 | Buy | $52.00 | +85.45% | Maintains | 11 days ago |
Xenon Pharmaceuticals IncXENE | 13 | Buy | $55.00 | +34.94% | Reiterates | 11 days ago |
Arcutis Biotherapeutics IncARQT | 23 | Buy | $30.00 | +20.00% | Maintains | 18 days ago |
Collegium Pharmaceutical IncCOLL | 22 | Buy | $46.00 | +0.04% | Reiterates | 18 days ago |
Ocular Therapeutix IncOCUL | 5 | Buy | $20.00 | +76.99% | Maintains | a month ago |
Moonlake ImmunotherapeuticsMLTX | 13 | Buy | $20.00 | +56.62% | Maintains | 2 months ago |
Kalvista Pharmaceuticals IncKALV | 19 | Buy | $28.00 | +105.58% | Reiterates | 2 months ago |
Cytokinetics IncCYTK | 24 | Buy | $72.00 | +8.37% | Reiterates | 2 months ago |
Heron Therapeutics IncHRTX | 21 | Buy | $3.00 | +172.73% | Maintains | 3 months ago |
Trevi Therapeutics IncTRVI | 20 | Buy | $22.00 | +93.49% | Maintains | 3 months ago |
Viridian Therapeutics IncVRDN | 18 | Buy | $34.00 | +18.18% | Maintains | 3 months ago |
Evolus IncEOLS | 16 | Hold | $22.00 | +204.71% | Downgrades | 3 months ago |
Clearside Biomedical IncCLSD | 16 | Hold | $45.00 | +1,078.01% | Downgrades | 4 months ago |
Pacira Biosciences IncPCRX | 27 | Buy | $30.00 | +26.16% | Maintains | 6 months ago |
Esperion Therapeutics IncESPR | 20 | Buy | $4.00 | +37.93% | Maintains | 6 months ago |
Verrica Pharmaceuticals IncVRCA | 14 | Hold | $120.00 | N/A | Downgrades | a year ago |
Revance Therapeutics IncRVNC | 16 | Buy | $12.00 | N/A | Reiterates | a year ago |
Dice Therapeutics IncDICE | 1 | Buy | $56.00 | N/A | Reiterates | 3 years ago |
Tricida IncTCDAQ | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Phasebio Pharmaceuticals IncPHASQ | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Aerie Pharmaceuticals IncAERI | 5 | Hold | N/A | N/A | Downgrades | 3 years ago |
Clarus Therapeutics Holdings IncCRXTQ | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Akebia Therapeutics IncAKBA | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Zogenix IncZGNX | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Flexion Therapeutics IncFLXN1 | 1 | Buy | $18.00 | N/A | Maintains | 4 years ago |
Calcimedica IncCALC | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Gw Pharmaceuticals PLCGWPH | 3 | Hold | N/A | N/A | Downgrades | 5 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.